These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Contribution of the KSHV and EBV lytic cycles to tumourigenesis. Manners O; Murphy JC; Coleman A; Hughes DJ; Whitehouse A Curr Opin Virol; 2018 Oct; 32():60-70. PubMed ID: 30268927 [TBL] [Abstract][Full Text] [Related]
6. NF-kappaB signaling modulation by EBV and KSHV. de Oliveira DE; Ballon G; Cesarman E Trends Microbiol; 2010 Jun; 18(6):248-57. PubMed ID: 20452220 [TBL] [Abstract][Full Text] [Related]
7. Tumor Microenvironment Conditioning by Abortive Lytic Replication of Oncogenic γ-Herpesviruses. Münz C Adv Exp Med Biol; 2020; 1225():127-135. PubMed ID: 32030652 [TBL] [Abstract][Full Text] [Related]
8. Gamma-herpesviruses and cellular signaling in AIDS-associated malignancies. Noguchi K; Fukazawa H; Murakami Y; Takahashi N; Yamagoe S; Uehara Y Cancer Sci; 2007 Sep; 98(9):1288-96. PubMed ID: 17640300 [TBL] [Abstract][Full Text] [Related]
9. Viral oncomiR spreading between B and T cells is employed by Kaposi's sarcoma herpesvirus to induce non-cell-autonomous target gene regulation. Rainy N; Zayoud M; Kloog Y; Rechavi O; Goldstein I Oncotarget; 2016 Jul; 7(27):41870-41884. PubMed ID: 27248822 [TBL] [Abstract][Full Text] [Related]
10. Herpesvirus Epigenetic Reprogramming and Oncogenesis. Pei Y; Wong JH; Robertson ES Annu Rev Virol; 2020 Sep; 7(1):309-331. PubMed ID: 32991266 [TBL] [Abstract][Full Text] [Related]
11. Viral Noncoding RNAs in Cancer Biology. Li Z; Fu S; Sun LQ Adv Exp Med Biol; 2016; 927():367-89. PubMed ID: 27376743 [TBL] [Abstract][Full Text] [Related]
12. Manipulation of the host cell membrane by human γ-herpesviruses EBV and KSHV for pathogenesis. Wei F; Zhu Q; Ding L; Liang Q; Cai Q Virol Sin; 2016 Oct; 31(5):395-405. PubMed ID: 27624182 [TBL] [Abstract][Full Text] [Related]
13. Noncoding RNAs produced by oncogenic human herpesviruses. Swaminathan S J Cell Physiol; 2008 Aug; 216(2):321-6. PubMed ID: 18484093 [TBL] [Abstract][Full Text] [Related]
14. K1 and K15 of Kaposi's Sarcoma-Associated Herpesvirus Are Partial Functional Homologues of Latent Membrane Protein 2A of Epstein-Barr Virus. Steinbrück L; Gustems M; Medele S; Schulz TF; Lutter D; Hammerschmidt W J Virol; 2015 Jul; 89(14):7248-61. PubMed ID: 25948739 [TBL] [Abstract][Full Text] [Related]
15. γ-Herpesvirus-encoded miRNAs and their roles in viral biology and pathogenesis. Zhu Y; Haecker I; Yang Y; Gao SJ; Renne R Curr Opin Virol; 2013 Jun; 3(3):266-75. PubMed ID: 23743127 [TBL] [Abstract][Full Text] [Related]
16. Immunodeficiencies that predispose to pathologies by human oncogenic γ-herpesviruses. Damania B; Münz C FEMS Microbiol Rev; 2019 Mar; 43(2):181-192. PubMed ID: 30649299 [TBL] [Abstract][Full Text] [Related]
17. HIV, EBV and KSHV: viral cooperation in the pathogenesis of human malignancies. da Silva SR; de Oliveira DE Cancer Lett; 2011 Jun; 305(2):175-85. PubMed ID: 21402436 [TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus recombinants from BC-1 and BC-2 can immortalize human primary B lymphocytes with different levels of efficiency and in the absence of coinfection by Kaposi's sarcoma-associated herpesvirus. Aguirre AJ; Robertson ES J Virol; 2000 Jan; 74(2):735-43. PubMed ID: 10623735 [TBL] [Abstract][Full Text] [Related]
19. Molecular biology of Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus. Swaminathan S Semin Hematol; 2003 Apr; 40(2):107-15. PubMed ID: 12704587 [TBL] [Abstract][Full Text] [Related]